Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutratopic pro-AMP (ISDIN)
- Development stage
- Unknown
- Lead developer
- ISDIN
- Administration
- Topical
01
Overview
Nutratopic pro-AMP is a topical dermo-cosmetic emollient developed by ISDIN for the prevention and management of atopic dermatitis (atopic eczema), particularly in infants and children. The product features a dual-action mechanism that restores the skin's physical barrier and reinforces its innate immune defense. Its key active ingredients include L-isoleucine, which stimulates the production of antimicrobial peptides (AMPs); Rhamnosoft (a rhamnose-rich polysaccharide), which inhibits bacterial adhesion (specifically *Staphylococcus aureus*) and provides anti-inflammatory activity; and Niacinamide, which enhances ceramide synthesis and reduces inflammation. Additional components like ceramides, glycerin, and shea butter further support lipid mantle restoration. It is formulated to be free of preservatives, perfumes, and dyes, making it suitable for sensitive pediatric skin from 5 months of age.
- Brand names
- Nutratopic pro-AMP
- Other names
- Nutratopic Pro-AMP Facial CreamNutratopic Pro-AMP Emollient Cream
02
Targets
Cer (Ceramide)
Beyond the preview
Go deeper on Nutratopic pro-AMP (ISDIN).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nutratopic pro-AMP (ISDIN).